View Financial HealthCore Scientific 배당 및 자사주 매입배당 기준 점검 0/6Core Scientific 배당금을 지급한 기록이 없습니다.핵심 정보n/a배당 수익률0.5%자사주 매입 수익률총 주주 수익률0.5%미래 배당 수익률0%배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향n/a최근 배당 및 자사주 매입 업데이트업데이트 없음모든 업데이트 보기Recent updates공시 • May 27Core Scientific, Inc. Appoints Steve Smith to Its Board of Directors and Nominating and Corporate Governance Committee, Effective May 26, 2026Core Scientific, Inc. announced the appointment of Steve Smith to its Board of Directors, effective May 26, 2026. Mr. Smith will also serve on the Company’s Nominating and Corporate Governance Committee. Mr. Smith, age 70, brings over 35 years of leadership experience in the data center, digital infrastructure and technology industries. He is currently Chief Executive Officer of Zayo Group, a global internet network provider since 2020. Previously, Mr. Smith served as CEO and President of Equinix from 2007 to 2018, where he led the company in scaling annual revenue from approximately $400 million to more than $4 billion and oversaw the successful integration of more than 20 acquisitions. Prior to Equinix, Mr. Smith held senior leadership roles at HP Services, Lucent Technologies and Electronic Data Systems Corporation. Mr. Smith currently serves on the boards of directors of Zayo and NEXTDC, a publicly traded Australian data center company. He graduated from the U.S. Military Academy at West Point with a Bachelor of Science in Engineering.Breakeven Date Change • May 11Forecast breakeven date pushed back to 2027The 13 analysts covering Core Scientific previously expected the company to break even in 2026. New consensus forecast suggests losses will reduce by 6.5% to 2026. The company is expected to make a profit of US$229.2m in 2027. Average annual earnings growth of 109% is required to achieve expected profit on schedule.Reported Earnings • May 07First quarter 2026 earnings released: US$1.08 loss per share (vs US$0.17 loss in 1Q 2025)First quarter 2026 results: US$1.08 loss per share (further deteriorated from US$0.17 loss in 1Q 2025). Revenue: US$115.2m (up 45% from 1Q 2025). Net loss: US$347.2m (loss widened US$293.5m from 1Q 2025). Revenue is forecast to grow 31% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Software industry in Italy.공시 • Apr 26Core Scientific, Inc. to Report Q1, 2026 Results on May 06, 2026Core Scientific, Inc. announced that they will report Q1, 2026 results After-Market on May 06, 2026공시 • Apr 01Core Scientific, Inc., Annual General Meeting, May 12, 2026Core Scientific, Inc., Annual General Meeting, May 12, 2026.Reported Earnings • Mar 03Full year 2025 earnings released: US$0.91 loss per share (vs US$4.39 loss in FY 2024)Full year 2025 results: US$0.91 loss per share (improved from US$4.39 loss in FY 2024). Revenue: US$319.0m (down 38% from FY 2024). Net loss: US$288.6m (loss narrowed 74% from FY 2024). Revenue is forecast to grow 36% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Software industry in Italy.공시 • Mar 03Core Scientific, Inc. Reports Impairment of Property, Plant and Equipment for the Fourth Quarter Ended December 31, 2025Core Scientific, Inc. reported impairment of property, plant and equipment of $11,359,000 for the fourth quarter ended December 31, 2025 against $25,608,000 a year ago.공시 • Feb 23Core Scientific, Inc. to Report Q4, 2025 Results on Mar 02, 2026Core Scientific, Inc. announced that they will report Q4, 2025 results After-Market on Mar 02, 2026공시 • Feb 20Core Scientific, Inc. Announces Jordan Levy Notifies That He Will Not Stand for Re-Election as Chairman of the Board of DirectorsOn February 18, 2026, Jordan Levy, the Chairman of the Board of Directors, notified the Core Scientific, Inc. and the Board of Directors that he will not stand for re-election at the 2026 Annual Meeting. His decision not to stand for re-election is not due to any disagreement with the Company.Board Change • Nov 25High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. No experienced directors. No highly experienced directors. Independent Director Eric Weiss is the most experienced director on the board, commencing their role in 2024. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 1CORZ 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: 1CORZ 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장Core Scientific 배당 수익률 vs 시장1CORZ의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (1CORZ)n/a시장 하위 25% (IT)1.6%시장 상위 25% (IT)4.6%업계 평균 (Software)2.0%분석가 예측 (1CORZ) (최대 3년)0%주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 1CORZ 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 1CORZ 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: 배당금 지급이 수익으로 충당되는지 확인하기 위해 1CORZ 의 지급 비율을 계산하기에는 데이터가 부족합니다.주주 현금 배당현금 흐름 범위: 1CORZ 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YIT 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/06/25 13:31종가2026/06/25 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 세부 정보는 당사의 Github 페이지에서 확인하실 수 있으며, 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Core Scientific, Inc.는 23명의 분석가가 다루고 있습니다. 이 중 17명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Andrew Charles BealeArete Research Services LLPRamsey El-AssalBarclaysGautam ChhuganiBernstein20명의 분석가 더 보기
공시 • May 27Core Scientific, Inc. Appoints Steve Smith to Its Board of Directors and Nominating and Corporate Governance Committee, Effective May 26, 2026Core Scientific, Inc. announced the appointment of Steve Smith to its Board of Directors, effective May 26, 2026. Mr. Smith will also serve on the Company’s Nominating and Corporate Governance Committee. Mr. Smith, age 70, brings over 35 years of leadership experience in the data center, digital infrastructure and technology industries. He is currently Chief Executive Officer of Zayo Group, a global internet network provider since 2020. Previously, Mr. Smith served as CEO and President of Equinix from 2007 to 2018, where he led the company in scaling annual revenue from approximately $400 million to more than $4 billion and oversaw the successful integration of more than 20 acquisitions. Prior to Equinix, Mr. Smith held senior leadership roles at HP Services, Lucent Technologies and Electronic Data Systems Corporation. Mr. Smith currently serves on the boards of directors of Zayo and NEXTDC, a publicly traded Australian data center company. He graduated from the U.S. Military Academy at West Point with a Bachelor of Science in Engineering.
Breakeven Date Change • May 11Forecast breakeven date pushed back to 2027The 13 analysts covering Core Scientific previously expected the company to break even in 2026. New consensus forecast suggests losses will reduce by 6.5% to 2026. The company is expected to make a profit of US$229.2m in 2027. Average annual earnings growth of 109% is required to achieve expected profit on schedule.
Reported Earnings • May 07First quarter 2026 earnings released: US$1.08 loss per share (vs US$0.17 loss in 1Q 2025)First quarter 2026 results: US$1.08 loss per share (further deteriorated from US$0.17 loss in 1Q 2025). Revenue: US$115.2m (up 45% from 1Q 2025). Net loss: US$347.2m (loss widened US$293.5m from 1Q 2025). Revenue is forecast to grow 31% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Software industry in Italy.
공시 • Apr 26Core Scientific, Inc. to Report Q1, 2026 Results on May 06, 2026Core Scientific, Inc. announced that they will report Q1, 2026 results After-Market on May 06, 2026
공시 • Apr 01Core Scientific, Inc., Annual General Meeting, May 12, 2026Core Scientific, Inc., Annual General Meeting, May 12, 2026.
Reported Earnings • Mar 03Full year 2025 earnings released: US$0.91 loss per share (vs US$4.39 loss in FY 2024)Full year 2025 results: US$0.91 loss per share (improved from US$4.39 loss in FY 2024). Revenue: US$319.0m (down 38% from FY 2024). Net loss: US$288.6m (loss narrowed 74% from FY 2024). Revenue is forecast to grow 36% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Software industry in Italy.
공시 • Mar 03Core Scientific, Inc. Reports Impairment of Property, Plant and Equipment for the Fourth Quarter Ended December 31, 2025Core Scientific, Inc. reported impairment of property, plant and equipment of $11,359,000 for the fourth quarter ended December 31, 2025 against $25,608,000 a year ago.
공시 • Feb 23Core Scientific, Inc. to Report Q4, 2025 Results on Mar 02, 2026Core Scientific, Inc. announced that they will report Q4, 2025 results After-Market on Mar 02, 2026
공시 • Feb 20Core Scientific, Inc. Announces Jordan Levy Notifies That He Will Not Stand for Re-Election as Chairman of the Board of DirectorsOn February 18, 2026, Jordan Levy, the Chairman of the Board of Directors, notified the Core Scientific, Inc. and the Board of Directors that he will not stand for re-election at the 2026 Annual Meeting. His decision not to stand for re-election is not due to any disagreement with the Company.
Board Change • Nov 25High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. No experienced directors. No highly experienced directors. Independent Director Eric Weiss is the most experienced director on the board, commencing their role in 2024. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.